P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
2,150.00
-35.00 (-1.60%)
At close: Mar 12, 2026
P&K Skin Research Center Market Cap
P&K Skin Research Center has a market cap or net worth of 62.96 billion as of March 13, 2026. Its market cap has decreased by -2.02% in one year.
Market Cap
62.96B
Enterprise Value
23.15B
Revenue
22.13B
Ranking
n/a
PE Ratio
9.47
Stock Price
2,150.00
Market Cap Chart
Since September 9, 2020, P&K Skin Research Center's market cap has decreased from 201.07B to 62.96B, a decrease of -68.69%. That is a compound annual growth rate of -19.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 62.10B | -16.02% |
| Dec 30, 2025 | 73.94B | 21.62% |
| Dec 30, 2024 | 60.80B | -17.65% |
| Dec 28, 2023 | 73.83B | -18.95% |
| Dec 29, 2022 | 91.08B | -33.84% |
| Dec 30, 2021 | 137.67B | -19.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 996.15B |
| DreamCIS | 127.80B |
| HLB bioStep | 103.39B |
| WOOJUNG BIO | 58.74B |
| C&R Research | 47.41B |
| DT&CRO CO. | 36.56B |
| SLS BIO | 26.89B |
| BioInfra | 16.71B |